| LITS Shares Outstanding History Table | ||||||
Below is a table of the LITS shares outstanding history going back to 9/23/2025:
Also see: LITS Market Cap History LITS YTD Return |

| LITS Shares Outstanding History Table | ||||||
Below is a table of the LITS shares outstanding history going back to 9/23/2025:
Also see: LITS Market Cap History LITS YTD Return |
| LITS Shares Outstanding History Chart | |||||||
LITS Historical Shares Outstanding: +5.10% CAGR
Mouse over chart for data details
| |||||||
| LITS Stock Price Chart |
| About Lite Strategy Inc |
| MEI Pharma, Inc. is a clinical-stage pharmaceutical company, which is engaged in developing novel and differentiated cancer therapies. Co.'s drug candidate pipeline includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, and ME-344, an intravenous small molecule mitochondrial inhibitor targeting the oxidative phosphorylation pathway. Voruciclib has completed a Phase I trial evaluating dose and schedule in patients with acute myeloid leukemia (AML) in combination with the B-cell lymphoma 2 (BCL-2) inhibitor venetoclax (marketed as Venclexta). We show 2 historical shares outstanding datapoints in our coverage of LITS's shares outstanding history. Understanding the changing numbers of LITS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LITS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LITS by allowing them to research LITS shares outstanding history as well as any other stock in our coverage universe. |
| LITS Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| LITS Share Performance |
| Shares Outstanding Peers |
| Lite Strategy (LITS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
LIXT Shares Outstanding History LJPC Shares Outstanding History LLY Shares Outstanding History LMAT Shares Outstanding History LMNX Shares Outstanding History LNSR Shares Outstanding History LNTH Shares Outstanding History LONA Shares Outstanding History LOXO Shares Outstanding History LPCN Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.